Report Detail
Global Hormonal Infertility Treatment Market Growth (Status and Outlook) 2022-2028
- RnM4404417 |
- 21 March, 2022 |
- Global |
- 86 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Hormonal Infertility Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Hormonal Infertility Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hormonal Infertility Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Hormonal Infertility Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hormonal Infertility Treatment market, reaching US$ million by the year 2028. As for the Europe Hormonal Infertility Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hormonal Infertility Treatment players cover Merck & Co. Inc, Par Pharmaceutical, TerSera Therapeutics LLC, and Teva Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hormonal Infertility Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Medications
Surgery
Assisted Reproductive Technology
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Specialty Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck & Co. Inc
Par Pharmaceutical
TerSera Therapeutics LLC
Teva Pharmaceuticals
AbbVie Inc
Sanofi S.A
Incepta Pharmaceuticals Ltd
Serum Institute of India Pvt. Ltd
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Hormonal Infertility Treatment Market Size 2017-2028
- 2.1.2 Hormonal Infertility Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Hormonal Infertility Treatment Segment by Type
- 2.2.1 Medications
- 2.2.2 Surgery
- 2.2.3 Assisted Reproductive Technology
- 2.2.4 Others
- 2.3 Hormonal Infertility Treatment Market Size by Type
- 2.3.1 Hormonal Infertility Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Hormonal Infertility Treatment Market Size Market Share by Type (2017-2022)
- 2.4 Hormonal Infertility Treatment Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Specialty Clinics
- 2.4.3 Others
- 2.5 Hormonal Infertility Treatment Market Size by Application
- 2.5.1 Hormonal Infertility Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Hormonal Infertility Treatment Market Size Market Share by Application (2017-2022)
3 Hormonal Infertility Treatment Market Size by Player
- 3.1 Hormonal Infertility Treatment Market Size Market Share by Players
- 3.1.1 Global Hormonal Infertility Treatment Revenue by Players (2020-2022)
- 3.1.2 Global Hormonal Infertility Treatment Revenue Market Share by Players (2020-2022)
- 3.2 Global Hormonal Infertility Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Hormonal Infertility Treatment by Regions
- 4.1 Hormonal Infertility Treatment Market Size by Regions (2017-2022)
- 4.2 Americas Hormonal Infertility Treatment Market Size Growth (2017-2022)
- 4.3 APAC Hormonal Infertility Treatment Market Size Growth (2017-2022)
- 4.4 Europe Hormonal Infertility Treatment Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Hormonal Infertility Treatment Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Hormonal Infertility Treatment Market Size by Country (2017-2022)
- 5.2 Americas Hormonal Infertility Treatment Market Size by Type (2017-2022)
- 5.3 Americas Hormonal Infertility Treatment Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Hormonal Infertility Treatment Market Size by Region (2017-2022)
- 6.2 APAC Hormonal Infertility Treatment Market Size by Type (2017-2022)
- 6.3 APAC Hormonal Infertility Treatment Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Hormonal Infertility Treatment by Country (2017-2022)
- 7.2 Europe Hormonal Infertility Treatment Market Size by Type (2017-2022)
- 7.3 Europe Hormonal Infertility Treatment Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Hormonal Infertility Treatment by Region (2017-2022)
- 8.2 Middle East & Africa Hormonal Infertility Treatment Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Hormonal Infertility Treatment Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Hormonal Infertility Treatment Market Forecast
- 10.1 Global Hormonal Infertility Treatment Forecast by Regions (2023-2028)
- 10.1.1 Global Hormonal Infertility Treatment Forecast by Regions (2023-2028)
- 10.1.2 Americas Hormonal Infertility Treatment Forecast
- 10.1.3 APAC Hormonal Infertility Treatment Forecast
- 10.1.4 Europe Hormonal Infertility Treatment Forecast
- 10.1.5 Middle East & Africa Hormonal Infertility Treatment Forecast
- 10.2 Americas Hormonal Infertility Treatment Forecast by Country (2023-2028)
- 10.2.1 United States Hormonal Infertility Treatment Market Forecast
- 10.2.2 Canada Hormonal Infertility Treatment Market Forecast
- 10.2.3 Mexico Hormonal Infertility Treatment Market Forecast
- 10.2.4 Brazil Hormonal Infertility Treatment Market Forecast
- 10.3 APAC Hormonal Infertility Treatment Forecast by Region (2023-2028)
- 10.3.1 China Hormonal Infertility Treatment Market Forecast
- 10.3.2 Japan Hormonal Infertility Treatment Market Forecast
- 10.3.3 Korea Hormonal Infertility Treatment Market Forecast
- 10.3.4 Southeast Asia Hormonal Infertility Treatment Market Forecast
- 10.3.5 India Hormonal Infertility Treatment Market Forecast
- 10.3.6 Australia Hormonal Infertility Treatment Market Forecast
- 10.4 Europe Hormonal Infertility Treatment Forecast by Country (2023-2028)
- 10.4.1 Germany Hormonal Infertility Treatment Market Forecast
- 10.4.2 France Hormonal Infertility Treatment Market Forecast
- 10.4.3 UK Hormonal Infertility Treatment Market Forecast
- 10.4.4 Italy Hormonal Infertility Treatment Market Forecast
- 10.4.5 Russia Hormonal Infertility Treatment Market Forecast
- 10.5 Middle East & Africa Hormonal Infertility Treatment Forecast by Region (2023-2028)
- 10.5.1 Egypt Hormonal Infertility Treatment Market Forecast
- 10.5.2 South Africa Hormonal Infertility Treatment Market Forecast
- 10.5.3 Israel Hormonal Infertility Treatment Market Forecast
- 10.5.4 Turkey Hormonal Infertility Treatment Market Forecast
- 10.5.5 GCC Countries Hormonal Infertility Treatment Market Forecast
- 10.6 Global Hormonal Infertility Treatment Forecast by Type (2023-2028)
- 10.7 Global Hormonal Infertility Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Merck & Co. Inc
- 11.1.1 Merck & Co. Inc Company Information
- 11.1.2 Merck & Co. Inc Hormonal Infertility Treatment Product Offered
- 11.1.3 Merck & Co. Inc Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Merck & Co. Inc Main Business Overview
- 11.1.5 Merck & Co. Inc Latest Developments
- 11.2 Par Pharmaceutical
- 11.2.1 Par Pharmaceutical Company Information
- 11.2.2 Par Pharmaceutical Hormonal Infertility Treatment Product Offered
- 11.2.3 Par Pharmaceutical Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Par Pharmaceutical Main Business Overview
- 11.2.5 Par Pharmaceutical Latest Developments
- 11.3 TerSera Therapeutics LLC
- 11.3.1 TerSera Therapeutics LLC Company Information
- 11.3.2 TerSera Therapeutics LLC Hormonal Infertility Treatment Product Offered
- 11.3.3 TerSera Therapeutics LLC Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 TerSera Therapeutics LLC Main Business Overview
- 11.3.5 TerSera Therapeutics LLC Latest Developments
- 11.4 Teva Pharmaceuticals
- 11.4.1 Teva Pharmaceuticals Company Information
- 11.4.2 Teva Pharmaceuticals Hormonal Infertility Treatment Product Offered
- 11.4.3 Teva Pharmaceuticals Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Teva Pharmaceuticals Main Business Overview
- 11.4.5 Teva Pharmaceuticals Latest Developments
- 11.5 AbbVie Inc
- 11.5.1 AbbVie Inc Company Information
- 11.5.2 AbbVie Inc Hormonal Infertility Treatment Product Offered
- 11.5.3 AbbVie Inc Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 AbbVie Inc Main Business Overview
- 11.5.5 AbbVie Inc Latest Developments
- 11.6 Sanofi S.A
- 11.6.1 Sanofi S.A Company Information
- 11.6.2 Sanofi S.A Hormonal Infertility Treatment Product Offered
- 11.6.3 Sanofi S.A Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Sanofi S.A Main Business Overview
- 11.6.5 Sanofi S.A Latest Developments
- 11.7 Incepta Pharmaceuticals Ltd
- 11.7.1 Incepta Pharmaceuticals Ltd Company Information
- 11.7.2 Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Product Offered
- 11.7.3 Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Incepta Pharmaceuticals Ltd Main Business Overview
- 11.7.5 Incepta Pharmaceuticals Ltd Latest Developments
- 11.8 Serum Institute of India Pvt. Ltd
- 11.8.1 Serum Institute of India Pvt. Ltd Company Information
- 11.8.2 Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Product Offered
- 11.8.3 Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Serum Institute of India Pvt. Ltd Main Business Overview
- 11.8.5 Serum Institute of India Pvt. Ltd Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Hormonal Infertility Treatment. Industry analysis & Market Report on Hormonal Infertility Treatment is a syndicated market report, published as Global Hormonal Infertility Treatment Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Hormonal Infertility Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
